is it safe to use glp 1 patches Beware of TikTok GLP-1 Patches: Health Scam Alert Do GLP-1 Patches Work for

Long-Term Outlook and Future Developments The obesity medication landscape continues evolving rapidly

Manufactured under strict quality standards to ensure consistent results

Conclusion Tirzepatide represents a major leap forward in the treatment of type 2 diabetes and obesity

Tirzepatide (Mounjaro) a dual GIP/GLP-1 receptor agonist licensed by the MHRA for type 2 diabetes

For context, this exceeds what semaglutide achieves in 68 weeks, and retatrutide did it in a shorter timeframe

And while there is decent data coming out about use of the medications, theres not much long term data on disease states and especially in overall healthy populations using these simply for weight loss